These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 2966629)

  • 21. [Effects of MY-5116 on experimental animal models of type I-type IV allergic reactions and the formation of IgE antibody].
    Takahashi K; Endoh K; Yamada N; Kadowaki S; Arai Y; Sugasawa K
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):245-54. PubMed ID: 2947841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin.
    Ohmori K; Ishii H; Manabe H; Satoh H; Tamura T; Kase H
    Arzneimittelforschung; 1988 Jun; 38(6):809-14. PubMed ID: 2972291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of the specificity in pharmacological inhibition of the passive cutaneous anaphylaxis reaction in mice and rats.
    Perper RJ; Oronsky AL; Blancuzzi V
    J Pharmacol Exp Ther; 1975 May; 193(2):594-602. PubMed ID: 49417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homologous passive cutaneous anaphylaxis (PCA) in mice and heterologous PCA induced in rats with mouse IgE.
    Braga F; Mota I
    Immunology; 1976 May; 30(5):655-69. PubMed ID: 179937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
    Kuriyama K; Hiyama Y; Ito K
    Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of YM-13650 on type I to type IV allergic reactions and immune responses in animals].
    Yamada T; Tomioka K; Mase T; Murase K
    Nihon Yakurigaku Zasshi; 1991 Feb; 97(2):75-84. PubMed ID: 1829062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of neurotropin (NSP) on allergic reactions (author's transl)].
    Koda A; Nagai H; Kurimoto Y; Yamada T; Mori H; Nishiyori T; Inagaki N
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):319-34. PubMed ID: 6173291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals.
    Siminoff P; Reed FC; Schurig JE; Juby PF
    Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB; Abboa-Offei BE; Marretta J
    J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 6-ethyl-3-(1H-tetrazol-5-yl)chromone (AA-344) on the immediate and delayed hypersensitivity reactions.
    Kuriki H; Saijo T; Ashida Y; Maki Y
    Jpn J Pharmacol; 1979 Oct; 29(5):733-44. PubMed ID: 161338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
    Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-allergic activities of the beta-adrenoceptor stimulant formoterol (BD 40A).
    Tomioka K; Yamada T; Ida H
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):279-92. PubMed ID: 6168241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on type I allergic reactions.
    Kohno SW; Murata T; Kinoshita T; Ohata K
    Arzneimittelforschung; 1986 Nov; 36(11):1619-27. PubMed ID: 2434110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of whisky congeners on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3 cells and passive cutaneous anaphylaxis reaction in mice.
    Itoh T; Tsukane M; Koike M; Nakamura C; Ohguchi K; Ito M; Akao Y; Koshimizu S; Nozawa Y; Wakimoto T; Nukaya H; Suwa Y
    J Agric Food Chem; 2010 Jun; 58(12):7149-57. PubMed ID: 20507065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of methanolic extract from corydalis tuber against types I-IV allergic models.
    Matsuda H; Tokuoka K; Wu J; Tanaka T; Kubo M
    Biol Pharm Bull; 1995 Jul; 18(7):963-7. PubMed ID: 7581251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of predosing with Y-12,141 on its antiallergic activity. --Studies on anti-allergic agents(IV)-- (author's transl)].
    Goto K; Terasawa M; Komori A; Maruyama Y
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):123-9. PubMed ID: 6786963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
    Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
    Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.
    Hiroi J; Ohara K; Kobayashi K; Fujitsu T; Fujii T; Motoyama Y; Mori J; Shibayama F
    Jpn J Pharmacol; 1988 Apr; 46(4):337-48. PubMed ID: 2457128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.